NO995935L - 17<beta>-allyloksy(tio)alkyl-androstan-derivater for modulering av meiose - Google Patents
17<beta>-allyloksy(tio)alkyl-androstan-derivater for modulering av meioseInfo
- Publication number
- NO995935L NO995935L NO995935A NO995935A NO995935L NO 995935 L NO995935 L NO 995935L NO 995935 A NO995935 A NO 995935A NO 995935 A NO995935 A NO 995935A NO 995935 L NO995935 L NO 995935L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- thio
- independently hydrogen
- meiosis
- alloxy
- Prior art date
Links
- 230000021121 meiosis Effects 0.000 title abstract 2
- 125000000446 sulfanediyl group Chemical group *S* 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical group 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 230000003213 activating effect Effects 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 150000001721 carbon Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 230000035558 fertility Effects 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
- C07J7/007—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Foreliggende oppfinnelse angår 17p-aHyloksy(tio)alkyl-androstanderivatermed den generelle formel l, hvor R, er (H,OR), (H, OSO3H) eller NOR; hvor R er H, (d- C6)alkyl eller (d-C6)acyl, og hvor hver R2 og R3 uavhengig av hverandre er hydrogen eller (d-C6)alkyl; n er O, 1 eller 2; X er O, S, S(O) eller S(O)2; hver R4 og R5 er uavhengig av hverandre hydrogen eller (d-C4)alkyl; hver R6l R? og R8 er uavhengig hydrogen, fenyl, halogen eller (d-C4)alkyl, eventuelt substituert med hydroksky, (d- C4)alkoksy eller halogen; eller R7 og R8 kan sammen med det karbonatom til hvilket de er knyttet, danne en (C3-C5)cykloalkanring; eller R6 og R7 sammen med de karbonatomertil hvilke de er knyttet, danner en (C5-C5)-cykloalkanring; og hvori de stiplede linjer indikerer en A7 eller en A8 dobbeltbinding, eller et par konjugerte dobbeltbindinger valgt fra A7'14, A8'14 og A6'8(14); eller et farmasøytisk åk eptabelt salt av en slik forbindelse. Forbindelsene ifølge oppfinnelsen har meioseaktiverende aktivitet og kan brukes for kontroll av fruktbarhet.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97201691 | 1997-06-04 | ||
| PCT/EP1998/003191 WO1998055498A1 (en) | 1997-06-04 | 1998-05-28 | 17β-ALLYLOXY(THIO)ALKYL-ANDROSTANE DERIVATIVES FOR THE MODULATION OF MEIOSIS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO995935D0 NO995935D0 (no) | 1999-12-03 |
| NO995935L true NO995935L (no) | 2000-02-03 |
Family
ID=8228406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO995935A NO995935L (no) | 1997-06-04 | 1999-12-03 | 17<beta>-allyloksy(tio)alkyl-androstan-derivater for modulering av meiose |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6262282B1 (no) |
| EP (1) | EP0988312B1 (no) |
| JP (1) | JP2002502404A (no) |
| KR (1) | KR20010013401A (no) |
| CN (1) | CN1259138A (no) |
| AT (1) | ATE215555T1 (no) |
| AU (1) | AU8535398A (no) |
| CA (1) | CA2289524A1 (no) |
| DE (1) | DE69804611T2 (no) |
| DK (1) | DK0988312T3 (no) |
| HU (1) | HUP0002904A2 (no) |
| IL (1) | IL132799A0 (no) |
| NO (1) | NO995935L (no) |
| PL (1) | PL337188A1 (no) |
| TR (1) | TR199902873T2 (no) |
| WO (1) | WO1998055498A1 (no) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999032506A1 (en) * | 1997-12-18 | 1999-07-01 | Akzo Nobel N.V. | 17β-ARYL (ARYLMETHYL) OXY(THIO)ALKYL -ANDROSTANE DERIVATIVES |
| BR9910415A (pt) * | 1998-05-13 | 2001-01-09 | Novo Nordisk As | Novos compostos, uso de compostos, e, processo de regular a meiose |
| JP2003521444A (ja) * | 1998-06-19 | 2003-07-15 | ノボ ノルディスク アクティーゼルスカブ | 減数分裂調節化合物 |
| EP1156822B1 (en) | 1999-02-24 | 2006-02-08 | Novo Nordisk A/S | Iin vitro method for synchronisation of oocyte maturation |
| DE60034662T2 (de) * | 1999-02-24 | 2008-01-03 | Novo Nordisk A/S | Behandlung von unfruchtbarkeit |
| ATE392899T1 (de) * | 1999-03-02 | 2008-05-15 | Organon Nv | (androst-5-en-17beta-yl)alkyl sulfoxide und sulfone und deren verwendung zur kontrolle der fruchtbarkeit |
| ES2204613T3 (es) * | 1999-04-06 | 2004-05-01 | Akzo Nobel N.V. | Androgenos 7-alfa alquilo oralmente activos. |
| WO2001019354A2 (en) | 1999-09-16 | 2001-03-22 | Novo Nordisk A/S | Composition for ivf |
| EP1127890A1 (en) | 2000-02-22 | 2001-08-29 | Schering Aktiengesellschaft | Steroid derivatives with an additional ring annulated to ring A and use of these derivatives for the preparation of meiosis regulating medicaments |
| WO2001062260A2 (en) * | 2000-02-25 | 2001-08-30 | Schering Aktiengesellschaft | Improvement of implantation rate |
| JP2003533222A (ja) * | 2000-05-18 | 2003-11-11 | シエーリング アクチエンゲゼルシャフト | 経年卵母細胞の受精 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5716777A (en) | 1994-06-23 | 1998-02-10 | Novo Nordisk A/S | Regulation of meiosis using sterols |
| KR19980702624A (ko) * | 1995-03-06 | 1998-08-05 | 슈타르 피아 | 감수분열의 자극 |
| CA2224866A1 (en) * | 1995-06-23 | 1997-01-09 | Novo Nordisk A/S | Meiosis regulating compounds |
-
1998
- 1998-05-28 EP EP98936293A patent/EP0988312B1/en not_active Expired - Lifetime
- 1998-05-28 AU AU85353/98A patent/AU8535398A/en not_active Abandoned
- 1998-05-28 CN CN98805807A patent/CN1259138A/zh active Pending
- 1998-05-28 DE DE69804611T patent/DE69804611T2/de not_active Expired - Fee Related
- 1998-05-28 IL IL13279998A patent/IL132799A0/xx unknown
- 1998-05-28 PL PL98337188A patent/PL337188A1/xx unknown
- 1998-05-28 WO PCT/EP1998/003191 patent/WO1998055498A1/en not_active Application Discontinuation
- 1998-05-28 DK DK98936293T patent/DK0988312T3/da active
- 1998-05-28 JP JP50144599A patent/JP2002502404A/ja not_active Ceased
- 1998-05-28 AT AT98936293T patent/ATE215555T1/de not_active IP Right Cessation
- 1998-05-28 TR TR1999/02873T patent/TR199902873T2/xx unknown
- 1998-05-28 US US09/445,202 patent/US6262282B1/en not_active Expired - Fee Related
- 1998-05-28 KR KR19997011402A patent/KR20010013401A/ko not_active Application Discontinuation
- 1998-05-28 CA CA002289524A patent/CA2289524A1/en not_active Abandoned
- 1998-05-28 HU HU0002904A patent/HUP0002904A2/hu unknown
-
1999
- 1999-12-03 NO NO995935A patent/NO995935L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998055498A1 (en) | 1998-12-10 |
| TR199902873T2 (xx) | 2000-04-21 |
| HUP0002904A2 (hu) | 2001-02-28 |
| ATE215555T1 (de) | 2002-04-15 |
| AU8535398A (en) | 1998-12-21 |
| CA2289524A1 (en) | 1998-12-10 |
| EP0988312A1 (en) | 2000-03-29 |
| PL337188A1 (en) | 2000-08-14 |
| CN1259138A (zh) | 2000-07-05 |
| DE69804611D1 (de) | 2002-05-08 |
| DK0988312T3 (da) | 2002-07-15 |
| IL132799A0 (en) | 2001-03-19 |
| JP2002502404A (ja) | 2002-01-22 |
| NO995935D0 (no) | 1999-12-03 |
| KR20010013401A (ko) | 2001-02-26 |
| US6262282B1 (en) | 2001-07-17 |
| DE69804611T2 (de) | 2002-10-02 |
| EP0988312B1 (en) | 2002-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO995935L (no) | 17<beta>-allyloksy(tio)alkyl-androstan-derivater for modulering av meiose | |
| ES2124545T3 (es) | Azolidindionas como agentes antihiperglucemicos. | |
| MY111702A (en) | 5-amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid derivative | |
| NO995590D0 (no) | 20-Aryl-5<alfa>-pregnan-derivater | |
| ATE223411T1 (de) | 1-methylcarbapenem-derivate | |
| ATE79629T1 (de) | 17-substituierte androsta-1,4-dien-3-on-derivate. | |
| ES472085A1 (es) | Un procedimiento para la preparacion de una composicion te- rapeutica para el tratamiento de enfermedades alergicas. | |
| ES2080182T3 (es) | Derivados espiro dibenzosuberano. | |
| NO921282D0 (no) | Benzotiazolderivater og deres anvendelse | |
| ATE86117T1 (de) | Zusammensetzung gegen leberkrankheiten. | |
| DE69806640T2 (de) | 17beta-aryl(arylmethyl)oxy(thio)alkyl-androstanderivative | |
| EP1112998A4 (en) | AMINE DERIVATIVES | |
| ATE255111T1 (de) | Abeo-ergolinderivate als 5ht1a liganden | |
| NO924947L (no) | Tetrazolderivater og legemidler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |